Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PFIMLE trial of preoperative ferric derisomaltose in elderly patients undergoing multilevel lumbar fusion
ChiCTR2500099482Phase 3Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Mar 2025
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ferric derisomaltose in degenerative spinal conditions (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Hemoglobin level at 4 weeks postoperatively. Started Mar 2025; status: recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
degenerative spinal conditions
Beyond the preview
Go deeper on ChiCTR2500099482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099482.